ZCP-14629-72025
4 vaccinations
13 coded responses
41 check-ins
12 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 850 / AZ
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Registered in v-safe
-
2021-03-19
Dose 1 — Pfizer-BioNTech
-
2021-03-19
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-24
Survey response — days 1–6 daily, dose 1MedDRA: Ageusia — Feeling: Fair · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Lost my sense of tasteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-25
-
2021-03-26
Health check-in — day 7, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-02
-
2021-04-10
Dose 2 — Pfizer-BioNTech
-
2021-04-10
Health check-in — day 0, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-15
Survey response — days 1–6 daily, dose 2MedDRA: Abdominal distension, Abdominal pain — Feeling: Fair · Chills, Joint pains, Muscle or body achesFree text: Cramping bloating abdomenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Survey response — days 1–6 daily, dose 2MedDRA: Abdominal distension, Abdominal pain — Feeling: Fair · Chills, Joint pains, Fatigue or tirednessFree text: Abdominal bloating and crampsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Survey response — day 7, dose 2MedDRA: Abdominal distension, Abdominal pain — Feeling: Fair · DiarrheaFree text: Abdominal cramping and bloatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-24
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-07-10
- 2021-10-09
-
2021-10-22
Dose 3 — Pfizer-BioNTech
-
2021-10-26
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-27
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-28
Survey response — days 1–6 daily, dose 3MedDRA: Office visit — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professionalFree text: Rheumatologist apptMedDRA releases: 2024-11 · check-in free text available
-
2021-10-28
Report sent to call center — days 1–6 daily, dose 3Get care from a doctor or other healthcare professional1 call case(s)
-
2021-10-29
Health check-in — day 7, dose 3Feeling: Poor · Site: Swelling · Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-02
- 2021-11-05
- 2021-11-12
- 2021-11-19
-
2021-11-26
Survey response — day 35, dose 3MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: inordinate fatigue has lingeredMedDRA releases: 2024-11 · check-in free text available
- 2021-12-04
-
2022-01-21
Survey response — 3 months, dose 3MedDRA: Asthma, Cough, Fatigue, Illness, Nasopharyngitis, Pre-existing disease, Somnolence — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough, cold symptoms, extreme fatigue (somnolence) NO FEVERS asthma extreme exacerbation still present 2 weeks after illness began NO GI SXSMedDRA releases: 2024-11 · check-in free text available
-
2022-03-27
Dose 4 — Moderna
-
2022-04-15
Survey response — day 14, dose 4MedDRA: Delirium, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: High fever and delirium for 4 days after booster 2MedDRA releases: 2024-11 · check-in free text available
-
2022-04-17
Survey response — day 21, dose 4MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Extreme fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-04-17
Report sent to call center — day 21, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-19
-
2022-04-26
Survey response — day 28, dose 4MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headache almost dailyMedDRA releases: 2024-11 · check-in free text available
- 2022-05-01
- 2022-05-08
-
2022-06-28
Survey response — 3 months, dose 4MedDRA: Cough, Decreased appetite, Diarrhoea, Fatigue, Pyrexia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fever cough diarrhea fatigue loss of appetiteMedDRA releases: 2024-11 · check-in free text available
-
2022-09-26
Survey response — 6 months, dose 4MedDRA: Adverse drug reaction, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: My RA is no longer being helped with the biologic I am onMedDRA releases: 2024-11 · check-in free text available
-
2023-03-27
Survey response — 12 months, dose 4MedDRA: Autoimmune disorder, Diabetic complication — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-27
Report sent to call center — 12 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-03-28
- 2023-03-28
- 2023-03-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Pfizer-BioNTech | |
| 2 | 2021-04-10 | Pfizer-BioNTech | |
| 3 | 2021-10-22 | Pfizer-BioNTech | No |
| 4 | 2022-03-27 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-28 | Unsuccessful | |
| 2022-04-17 | Unsuccessful | |
| 2023-03-27 | Unsuccessful |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Lost my sense of taste
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Cramping bloating abdomen
Systemic reaction (other): Abdominal bloating and cramps
Release 7 — day 7, dose 2
Systemic reaction (other): Abdominal cramping and bloating
Release 10 — days 1–6 daily, dose 3
Healthcare visit (other): Rheumatologist appt
Release 10 — day 35, dose 3
Symptoms: inordinate fatigue has lingered
Release 11 — 3 months, dose 3
Symptoms: Cough, cold symptoms, extreme fatigue (somnolence) NO FEVERS asthma extreme exacerbation still present 2 weeks after illness began NO GI SXS
Release 11 — day 14, dose 4
Symptoms: High fever and delirium for 4 days after booster 2
Release 11 — day 21, dose 4
Symptoms: Extreme fatigue
Release 11 — day 28, dose 4
Symptoms: Headache almost daily
Release 12 — 3 months, dose 4
Symptoms: Fever cough diarrhea fatigue loss of appetite
Release 12 — 6 months, dose 4
Symptoms: My RA is no longer being helped with the biologic I am on
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Adverse drug reaction | · | · | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Autoimmune disorder | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Delirium | · | · | ✓ |
| SD | Diabetic complication | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Illness | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Somnolence | · | · | ✓ |
| SRO | Abdominal distension | ✓ | ✓ | ✓ |
| SRO | Abdominal pain | ✓ | ✓ | ✓ |
| SRO | Ageusia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release